Johnson & Johnson | The Business Standard
Skip to main content
  • Home
  • Economy
  • Analysis
  • Bangladesh
  • World
  • Sports
  • Glitz
  • Feature
  • Long Read
  • PSI
  • Games
  • epaper
  • More
    • COVID-19
    • Top News
    • Companies
    • Environment
    • Infograph
    • Interviews
    • Markets
    • Special Stories
    • Multimedia/videos
    • Offbeat
    • Panorama
    • Thoughts
    • Science
    • Splash
    • Tech
    • Subscribe
    • Archive
  • বাংলা
The Business Standard
WEDNESDAY, MARCH 03, 2021
WEDNESDAY, MARCH 03, 2021
  • Home
  • Economy
  • Analysis
  • Bangladesh
  • World
  • Sports
  • Glitz
  • Feature
  • Long Read
  • PSI
  • Games
  • epaper
  • More
    • COVID-19
    • Top News
    • Companies
    • Environment
    • Infograph
    • Interviews
    • Markets
    • Special Stories
    • Multimedia/videos
    • Offbeat
    • Panorama
    • Thoughts
    • Science
    • Splash
    • Tech
    • Subscribe
    • Archive
  • বাংলা

Johnson & Johnson

Coronavirus chronicle

US to distribute 4 million J&J Covid vaccines by Tuesday

The J&J vaccine requires just one dose and is stored at fridge temperatures, offering logistical and practical advantages

Analysis

What J&J's authorized Covid-19 shot means for the US vaccination campaign

Coronavirus chronicle

Details about J&J Covid-19 vaccine authorized in US

Coronavirus chronicle

US advisers endorse single-shot Covid-19 vaccine from J&J

Global Economy

Johnson & Johnson sets aside almost $4 billion for talc verdict, filing shows

Coronavirus chronicle

Johnson & Johnson has only a few million vaccine doses in stock as likely launch nears

Coronavirus chronicle

Fresh data show toll South African virus variant takes on vaccine efficacy

Coronavirus chronicle

J&J may not meet US Covid-19 vaccine supply target by spring

Coronavirus chronicle

J&J enrolls about 45,000 participants for late-stage Covid-19 vaccine trial

Coronavirus chronicle

J&J starts two-dose trial of its Covid-19 candidate vaccine in the UK

Coronavirus chronicle

J&J pauses Covid-19 vaccine trials due to unexplained illness in participant

Coronavirus chronicle

Johnson & Johnson Covid-19 vaccine produces strong immune response in early trial

Coronavirus chronicle

J&J signs manufacturing deal with GRAM for potential Covid-19 vaccine

  • Show More
The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]

Copyright © 2021 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab